Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives

被引：3
|
作者：
Haddad, Fady G. [1 ]
Kourie, Hampig R. [1 ,2 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Fac Med, Dept Oncol, Beirut, Lebanon
[2] Bordet Inst, Fac Med, Brussels, Belgium
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 03期
关键词：
EGFR; non-small-cell lung cancer; T790M; CISPLATIN PLUS GEMCITABINE; 1ST-LINE TREATMENT; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; GEFITINIB; AFATINIB; ERLOTINIB;
D O I：
10.2217/fon-2016-0325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：201 / 204
页数：4
相关论文
共 50 条
  • [31] Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer
    Kimura, Hideharu
    Ohira, Tatsuo
    Uchida, Osamu
    Matsubayashi, Jun
    Shimizu, Shinichiro
    Nagao, Toshitaka
    Ikeda, Norihiko
    Nishio, Kazuto
    [J]. LUNG CANCER, 2014, 83 (03) : 329 - 333
  • [32] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. MODERN PATHOLOGY, 2009, 22 : 364A - 364A
  • [34] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 364A - 364A
  • [35] EGFR and HER2 mutation and gene amplification in non-small-cell lung cancer
    Toshihiko, Yokoyama
    Kondo, Masashi
    Goto, Yasuhiro
    Fukui, Takayuki
    Yoshioka, Hiromu
    Yokoi, Kohei
    Kondo, Yutaka
    Osada, Hirotaka
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Sekido, Yoshitaka
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [36] EGFR mutations in non-small-cell lung cancer reply
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    [J]. LANCET ONCOLOGY, 2010, 11 (05): : 413 - 413
  • [37] Targeting RET-rearranged non-small-cell lung cancer: future prospects
    Bronte, Giuseppe
    Ulivi, Paola
    Verlicchi, Alberto
    Cravero, Paola
    Delmonte, Angelo
    Crino, Lucio
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2019, 10 : 27 - 36
  • [38] Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
    Uras, Iris Z.
    Moll, Herwig P.
    Casanova, Emilio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 30
  • [39] Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges
    Matikas, Alexios
    Syrigos, Konstantinos N.
    Agelaki, Sofia
    [J]. CLINICAL LUNG CANCER, 2016, 17 (06) : 507 - 516
  • [40] Optimal radiotherapy for non-small-cell lung cancer: Current progress and future challenges
    Ishikura S.
    [J]. General Thoracic and Cardiovascular Surgery, 2012, 60 (3) : 127 - 131
12345